Novo Nordisk Annual Report 2021
Contents
Introducing Novo Nordisk
Strategic Aspirations
Key risks Management
Consolidated statements
Additional information
Novo Nordisk Annual Report 2021 94
Statement on management review
Management is responsible for the management review.
Our opinion on the consolidated financial statements and the parent financial statements
does not cover the management review, and we do not express any form of assurance
conclusion thereon.
In connection with our audit of the consolidated financial statements and the parent
financial statements, our responsibility is to read the management review and, in
doing so, consider whether the management review is materially inconsistent with the
consolidated financial statements and the parent financial statements or our knowledge
obtained in the audit or otherwise appears to be materially misstated.
Moreover, it is our responsibility to consider whether the management review provides
the information required under the Danish Financial Statements Act.
Based on the work we have performed, we conclude that the management review
is in accordance with the consolidated financial statements and the parent financial
statements and has been prepared in accordance with the requirements of the
Danish Financial Statements Act. We did not identify any material misstatement of the
management review.
Management's responsibilities for the Financial Statements
Management is responsible for the preparation of consolidated financial statements that
give a true and fair view in accordance with International Financial Reporting Standards
as endorsed by the EU and additional requirements of the Danish Financial Statements
Act as well as the preparation of parent financial statements that give a true and fair view
in accordance with the Danish Financial Statements Act, and for such internal control as
Management determines is necessary to enable the preparation of consolidated financial
statements and parent financial statements that are free from material misstatement,
whether due to fraud or error.
In preparing the consolidated financial statements and the parent financial statements,
Management is responsible for assessing the Group's and the Parent's ability to continue
as a going concern, for disclosing, as applicable, matters related to going concern, and
for using the going concern basis of accounting in preparing the consolidated financial
statements and the parent financial statements unless Management either intends to
liquidate the Group or the Entity or to cease operations, or has no realistic alternative but
to do so.
Auditor's responsibilities for the audit of the Financial Statements
Our objectives are to obtain reasonable assurance about whether the consolidated
financial statements and the parent financial statements as a whole are free from
material misstatement, whether due to fraud or error, and to issue an auditor's report
that includes our opinion. Reasonable assurance is a high level of assurance, but is
not a guarantee that an audit conducted in accordance with ISAS and the additional
requirements applicable in Denmark will always detect a material misstatement when
it exists. Misstatements can arise from fraud or error and are considered material
if, individually or in the aggregate, they could reasonably be expected to influence
the economic decisions of users taken on the basis of these consolidated financial
statements and these parent financial statements.
As part of an audit conducted in accordance with ISAs and the additional requirements
applicable in Denmark, we exercise professional judgement and maintain professional
scepticism throughout the audit. We also:
- Identify and assess the risks of material misstatement of the consolidated financial
statements and the parent financial statements, whether due to fraud or error,
design and perform audit procedures responsive to those risks, and obtain audit
evidence that is sufficient and appropriate to provide a basis for our opinion. The risk
of not detecting a material misstatement resulting from fraud is higher than for one
resulting from error, as fraud may involve collusion, forgery, intentional omissions,
misrepresentations, or the override of internal control.
- Obtain an understanding of internal control relevant to the audit in order to design
audit procedures that are appropriate in the circumstances, but not for the purpose
of expressing an opinion on the effectiveness of the Group's and the Parent's internal
control.
- Evaluate the appropriateness of accounting policies used and the reasonableness of
accounting estimates and related disclosures made by Management.
- Conclude on the appropriateness of Management's use of the going concern basis
of accounting in preparing the consolidated financial statements and the parent
financial statements, and, based on the audit evidence obtained, whether a material
uncertainty exists related to events or conditions that may cast significant doubt on
the Group's and the Parent's ability to continue as a going concern. If we conclude that
a material uncertainty exists, we are required to draw attention in our auditor's report
to the related disclosures in the consolidated financial statements and the parent
financial statements or, if such disclosures are inadequate, to modify our opinion. Our
conclusions are based on the audit evidence obtained up to the date of our auditor's
report. However, future events or conditions may cause the Group and the Entity to
cease to continue as a going concern.
- Evaluate the overall presentation, structure and content of Financial Statements,
including the disclosures in the notes, and whether the Financial Statements represent
the underlying transactions and events in a manner that gives a true and fair view.
- Obtain sufficient appropriate audit evidence regarding the financial information of
the entities or business activities within the Group to express an opinion on the
consolidated financial statements. We are responsible for the direction, supervision and
performance of the group audit. We remain solely responsible for our audit opinion.
We communicate with those charged with governance regarding, among other matters,
the planned scope and timing of the audit and significant audit findings, including any
significant deficiencies in internal control that we identify during our audit.
We also provide those charged with governance with a statement that we have complied
with relevant ethical requirements regarding independence, and to communicate with
them all relationships and other matters that may reasonably be thought to bear on our
independence, and, where applicable, safeguards put in place and measures taken to
eliminate threats.
From the matters communicated with those charged with governance, we determine
those matters that were of most significance in the audit of the Financial Statements of
the current period and are therefore the key audit matters. We describe these matters
in our auditor's report unless law or regulation precludes public disclosure about the
matter or when, in extremely rare circumstances, we determine that a matter should not
be communicated in our report because the adverse consequences of doing so would
reasonably be expected to outweigh the public interest benefits of such communication.
Report on compliance with the ESEF Regulation
As part of our audit of the Financial Statements of Novo Nordisk A/S, we performed
procedures to express an opinion on whether the annual report of Novo Nordisk A/S
for the financial year 1 January 2021 to 31 December 2021 with the file name NOVO-
2021-12-31.zip is prepared, in all material respects, in compliance with the Commission
Delegated Regulation (EU) 2019/815 on the European Single Electronic Format (ESEF
Regulation), which includes requirements related to the preparation of the annual report
in XHTML format and iXBRL tagging of the consolidated financial statements.
Management is responsible for preparing an annual report that complies with the ESEF
Regulation. This responsibility includes:
- The preparing of the annual report in XHTML format;
- The selection and application of appropriate iXBRL tags, including extensions to the
ESEF taxonomy and the anchoring thereof to elements in the taxonomy, for financial
information required to be tagged using judgement where necessary;
- Ensuring consistency between iXBRL tagged data and the consolidated financial
statements presented in human readable format; and
- For such internal control as Management determines necessary to enable the
preparation of an annual report that is compliant with the ESEF Regulation.
Our responsibility is to obtain reasonable assurance on whether the annual report is
prepared, in all material respects, in compliance with the ESEF Regulation based on the
evidence we have obtained and to issue a report that includes our opinion. The nature,
timing and extent of procedures selected depend on the auditor's judgement, including
the assessment of the risks of material departures from the requirements set out in the
ESEF Regulation, whether due to fraud or error. The procedures include:
- Testing whether the annual report is prepared in XHTML format;
- Obtaining an understanding of the Company's iXBRL tagging process and of internal
control over the tagging process;
- Evaluating the completeness of the iXBRL tagging of the consolidated financial
statements;
- Evaluating the appropriateness of the Company's use of iXBRL elements selected from
the ESEF taxonomy and the creation of extension elements where no suitable element
in the ESEF taxonomy has been identified;
- Evaluating the use of anchoring of extension elements to elements in the ESEF
taxonomy; and
- Reconciling the iXBRL tagged data with the audited consolidated financial statements.
In our opinion, the annual report of Novo Nordisk A/S for the financial year 1 January to
31 December 2021 with the file name NOVO-2021-12-31.zip is prepared in all material
respects, in compliance with the ESEF Regulation.
Copenhagen, 2 February 2022.
Deloitte
Statsautoriseret Revisionspartnerselskab
Business Registration No 33 96 35 56
Anders Vad Dons
State-Authorised Public Accountant
mne25299View entire presentation